Kari Wisinski ABRCC-2

    Clinical Researchers Showcase Series - December 2016

    Translational Medicine Research:

 View from the Trenches Newsletter


Brought to you by:

Criterium Logo Alt Tag Line w Globe Banner 2

Translational science is motivated by the need to provide effective treatments to the right patients at the right doses for a specific disease indication). The term is used mostly in the health sciences and refers to real-time translation of bench science, conducted

only in a lab, to bedside clinical practice or dissemination

to population-based community interventions.

-  Source: NIH -- Read more

from the
Academic Breast Cancer Consortium

ABRCC Researcher Spotlight:

MEET Dr. Kari Wisinski, MD
Univ of Wisconsin School of Medicine, Madison WI

ABRCC Investigator

Dr. Kari Wisinski, an Assoc. Professor (CHS) at Univ of Wisconsin School of Medicine Hematology/Oncology Division is a medical oncologist with UW School of Medicine and Public Health and the Carbone Cancer Center in Madison, Wisconsin, and is a member of the UW Health Breast Center.

Dr. Wisinski obtained her medical degree from Washington University School of Medicine in 2001. She then completed internal medicine residency at the University of Colorado Health Sciences Center, followed by a combined hematology and oncology fellowship at Northwestern University. She is board certified in hematology and medical oncology.

Dr. Wisinski on Palbociclib for Metastatic Breast Cancer

In 2008, she joined the University of Wisconsin School of Medicine and Public Health in the Division of Hematology/Oncology. Her clinical expertise involves the care of patients with breast cancer. Dr. Wisinski’s research is focused on designing and running clinical trials testing targeted agents for breast cancer, with a particular focus on phase I trials and triple negative breast cancer. Dr. Wisinski is also co-Director of the Wisconsin Oncology Network, a statewide medical oncology research group and co-Leader of the Big Ten Cancer Research Consortium Breast Cancer Working Group.

See Dr. Wisinski on YouTube

About University of Wisconsin Carbone Cancer Center

UW Health consists of the academic health care entities of the University of Wisconsin-Madison: UW Medical Foundation, UW Hospital and Clinics and UW School of Medicine and Public Health. UW Health is also home to American Family Children's Hospital and UW Carbone Cancer Center. Our expert doctors are at the forefront of research, developing new treatments and training the next generation of physicians. Together with other health care professionals, they serve the health needs of Wisconsin, and beyond. By combining our resources into one system, we are able to offer a network of primary and specialty care clinics throughout southcentral Wisconsin and beyond.. Learn more at UWHealth.


for Translational Research

The important conceptual difference between the two predominant research group approaches used today (a Clinical Trials Group vs. Consortia) is seen in this consortia model.  With its highly experienced clinical scientists, ABRCC becomes involved on an intellectual advisory level with every step of clinical investigation in a breast cancer study. Classical clinical trials groups "just run the study" with the main substantive role being patient accrual.


To read more on ABRCC and the details of why the consortia model creates fast results, please visit our website.

The Oncology Consortia of Criterium

The Oncology Consortia of Criterium Global CRO are a collaboration of outstanding Cancer Research Consortia that deliver innovative research and unparalleled expertise:

  • AGICC:  Academic GI Cancer Consortium
  • AMyC:  Academic Myeloma Consortium
  • ATOMIC:  Academic Thoracic Oncology Medical Investigators Consortium
  • ABRCC:  Academic Breast Cancer Consortium

ABRCC Cube FULL Logo 2

Read more about Criterium Inc Global CRO

and The Oncology Consortia of Criterium on our website